• Just what the doctor ordered

  The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon

  December 23, 2017

• Nursing Back to Health

  A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players

  Jash Kriplani - October 18, 2017

• Bold and Bountiful

  Not content with the initial win in biosimiliars, Kiran Mazumdar-Shaw is pushing new frontiers in biologics

  Kripa Mahalingam - July 11, 2017

• A Bitter Pill

  Regulatory woes continue to pile up for pharma companies

  Kripa Mahalingam - May 12, 2017

• A new prescription

  Tectonic changes in the US generic drugs market is causing  huge shifts in Indian pharma’s strategies as well 

  Team Outlook Business - December 17, 2015